VISUfarma España Revenue and Competitors
Estimated Revenue & Valuation
- VISUfarma España's estimated annual revenue is currently $3.2M per year.
- VISUfarma España's estimated revenue per employee is $201,000
Employee Data
- VISUfarma España has 16 Employees.
- VISUfarma España grew their employee count by 100% last year.
VISUfarma España's People
| Name | Title | Email/Phone |
|---|
VISUfarma España Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $13.1M | 65 | 30% | N/A | N/A |
#2 | $8.8M | 44 | N/A | N/A | N/A |
#3 | $4.6M | 23 | 0% | N/A | N/A |
#4 | $10.5M | 52 | 0% | N/A | N/A |
#5 | $2.4M | 12 | 100% | N/A | N/A |
#6 | $23.9M | 119 | 43% | N/A | N/A |
#7 | $1.6M | 8 | -47% | N/A | N/A |
#8 | $33.8M | 168 | 9% | N/A | N/A |
#9 | $0.2M | 1 | -50% | N/A | N/A |
#10 | $42.8M | 213 | 16% | N/A | N/A |
What Is VISUfarma España?
VISUfarma es una empresa farmacéutica paneuropea especializada en oftalmología con una clara misión: traer a Europa los avances en salud ocular de todo el mundo. Nuestro compromiso es ofrecer productos de alta calidad y difundir en toda Europa las innovaciones y conocimientos en salud ocular de todo el mundo. Actualmente Visufarma posee la patente de Coenzima Q10 con indicación oftálmica, principal molécula de nuestros productos.
keywords:N/A
N/A
Total Funding
16
Number of Employees
$3.2M
Revenue (est)
100%
Employee Growth %
N/A
Valuation
N/A
Accelerator
VISUfarma España News
2022-04-17 - El mercado de tratamiento del síndrome del ojo seco espera ...
Ltd., VISUfarma, Akorn Operating Company LLC, Bausch & Lomb Incorporated, ... Alemania, Italia, Reino Unido, Francia, España, Países Bajos,...
Other Companies in Madrid
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $2.1M | 16 | 78% | N/A |
#2 | $1.4M | 16 | -11% | N/A |
#3 | $2.2M | 16 | 23% | N/A |
#4 | $1.4M | 16 | -11% | N/A |
#5 | $2M | 16 | 14% | N/A |